The role of properdin in the assembly of the alternative pathway C3 convertases of complement

被引:180
作者
Hourcade, DE [1 ]
机构
[1] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M508928200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complement is a powerful host defense system that contributes to both innate and acquired immunity. There are three pathways of complement activation, the classical pathway, lectin pathway, and alternative pathway. Each generates a C3 convertase, a serine protease that cleaves the central complement protein, C3. Nearly all the biological consequences of complement are dependent on the resulting cleavage products. Properdin is a positive regulator of complement activation that stabilizes the alternative pathway convertases (C3bBb). Properdin is composed of multiple identical protein subunits, with each subunit carrying a separate ligand-binding site. Previous reports suggest that properdin function depends on multiple interactions between its subunits with its ligands. In this study I used surface plasmon resonance assays to examine properdin interactions with C3b and factor B. I demonstrated that properdin promotes the association of C3b with factor B and provides a focal point for the assembly of C3bBb on a surface. I also found that properdin binds to preformed alternative pathway C3 convertases. These findings support a model in which properdin, bound to a target surface via C3b, iC3b, or other ligands, can use its unoccupied C3b-binding sites as receptors for nascent C3b, bystander C3b, or pre-formed C3bB and C3bBb complexes. New C3bP and C3bBP intermediates can lead to in situ assembly of C3bBbP. The full stabilizing effect of properdin on C3bBb would be attained as properdin binds more than one ligand at a time, forming a lattice of properdin: ligand interactions bound to a surface scaffold.
引用
收藏
页码:2128 / 2132
页数:5
相关论文
共 31 条
[11]   Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55) [J].
Harris, CL ;
Abbott, RJM ;
Smith, RA ;
Morgan, BP ;
Lea, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (04) :2569-2578
[12]  
HOLT GD, 1990, J BIOL CHEM, V265, P2852
[13]   THE REGULATORS OF COMPLEMENT ACTIVATION (RCA) GENE-CLUSTER [J].
HOURCADE, D ;
HOLERS, VM ;
ATKINSON, JP .
ADVANCES IN IMMUNOLOGY, 1989, 45 :381-416
[14]   ANALYSIS OF THE SHORT CONSENSUS REPEATS OF HUMAN-COMPLEMENT FACTOR-B BY SITE-DIRECTED MUTAGENESIS [J].
HOURCADE, DE ;
WAGNER, LM ;
OGLESBY, TJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19716-19722
[15]   Complement factor H polymorphism in age-related macular degeneration [J].
Klein, RJ ;
Zeiss, C ;
Chew, EY ;
Tsai, JY ;
Sackler, RS ;
Haynes, C ;
Henning, AK ;
SanGiovanni, JP ;
Mane, SM ;
Mayne, ST ;
Bracken, MB ;
Ferris, FL ;
Ott, J ;
Barnstable, C ;
Hoh, J .
SCIENCE, 2005, 308 (5720) :385-389
[16]  
Kolble K, 1993, Int Rev Immunol, V10, P17, DOI 10.3109/08830189309051169
[17]   MAPPING OF THE PROPERDIN-BINDING SITE IN THE 3RD COMPONENT OF COMPLEMENT [J].
LAMBRIS, JD ;
ALSENZ, J ;
SCHULZ, TF ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1984, 217 (01) :323-326
[18]  
LISZEWSKI MK, 1998, HUMAN COMPLEMENT SYS, P149
[19]   Complement: more than a 'guard' against invading pathogens? [J].
Mastellos, D ;
Lambris, JD .
TRENDS IN IMMUNOLOGY, 2002, 23 (10) :485-491
[20]   ALTERNATIVE PATHWAY OF COMPLEMENT - RECRUITMENT OF PRECURSOR PROPERDIN BY LABILE C3-C5 CONVERTASE AND POTENTIATION OF PATHWAY [J].
MEDICUS, RG ;
GOTZE, O ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (04) :1076-1093